In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary


linsitinib 
An orally bioavailable small molecule inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. Linsitinib selectively inhibits IGF-1R, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Overexpressed in a variety of human cancers, IGFR-1 stimulates cell proliferation, enables oncogenic transformation, and suppresses apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Code name:OSI-906